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Abstract
Background: Accumulating evidence implicates early life factors in the aetiology of non-communicable diseases, including
asthma/wheezing disorders. We undertook a systematic review investigating risks of asthma/wheezing disorders in children
born preterm, including the increasing numbers who, as a result of advances in neonatal care, now survive very preterm
birth.
Methods and Findings: Two reviewers independently searched seven online databases for contemporaneous (1 January
1995–23 September 2013) epidemiological studies investigating the association between preterm birth and asthma/
wheezing disorders. Additional studies were identified through reference and citation searches, and contacting
international experts. Quality appraisal was undertaken using the Effective Public Health Practice Project instrument. We
pooled unadjusted and adjusted effect estimates using random-effects meta-analysis, investigated ‘‘dose–response’’
associations, and undertook subgroup, sensitivity, and meta-regression analyses to assess the robustness of associations.
We identified 42 eligible studies from six continents. Twelve were excluded for population overlap, leaving 30 unique
studies involving 1,543,639 children. Preterm birth was associated with an increased risk of wheezing disorders in
unadjusted (13.7% versus 8.3%; odds ratio [OR] 1.71, 95% CI 1.57–1.87; 26 studies including 1,500,916 children) and adjusted
analyses (OR 1.46, 95% CI 1.29–1.65; 17 studies including 874,710 children). The risk was particularly high among children
born very preterm (,32 wk gestation; unadjusted: OR 3.00, 95% CI 2.61–3.44; adjusted: OR 2.81, 95% CI 2.55–3.12). Findings
were most pronounced for studies with low risk of bias and were consistent across sensitivity analyses. The estimated
population-attributable risk of preterm birth for childhood wheezing disorders was $3.1%. Key limitations related to the
paucity of data from low- and middle-income countries, and risk of residual confounding.
Conclusions: There is compelling evidence that preterm birth—particularly very preterm birth—increases the risk of
asthma. Given the projected global increases in children surviving preterm births, research now needs to focus on
understanding underlying mechanisms, and then to translate these insights into the development of preventive
interventions.
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Introduction
The impact of early life exposures on subsequent health and
disease is increasingly recognised [1]. Preterm birth is a common
early life event, the adverse consequences of which can affect the
entire life course. Worldwide, over 11% of babies are born
preterm, a number that continues to rise in most regions [2].
Prevention of preterm birth is currently limited by a knowledge
gap regarding the mechanisms of normal and pathological labour
onset [3]. Given the increasing burden of preterm birth and the
restricted scope for prevention, a focus on appreciating and
containing its consequences is warranted.
Respiratory distress syndrome is the most obvious direct
manifestation of immaturity in preterm newborns. The combina-
tion of structural lung immaturity and pulmonary surfactant
deficiency results in regional atelectasis and a varying degree of
respiratory compromise [4]. Ventilatory support and additional
oxygen supplementation are common necessities, and many very
preterm babies go on to develop chronic lung disease (broncho-
pulmonary dysplasia [BPD]) [5]. The majority of preterm babies
are, however, born close to term, when respiratory compromise is
a less common event. Whereas late preterm babies have long been
regarded a normal variation of term babies, it is increasingly
recognised that they are at risk of a range of adverse outcomes,
including respiratory disease [6].
Accumulating evidence now implicates preterm birth in the
development of respiratory disease in later life. Small airway
obstruction is evident through decreased forced expiratory volume
in 1 s (FEV1) in children and adults born preterm [7], and a
hypothesized link with chronic obstructive pulmonary disease in
adulthood was recently confirmed [8]. Along this line of evidence,
a meta-analysis published in 2006 identified preterm birth as a risk
factor for asthma in a mixed paediatric and adult population [9].
Asthma is the most common chronic disease affecting children,
and its link with preterm birth is of significant public health
relevance given the increasing incidence of both entities [2,10]. Of
note, the majority of cohorts aggregated in this meta-analysis were
born before the 1990s [9]. Important changes in neonatal clinical
management have been introduced since, including increased use
of antenatal steroids and postnatal surfactant, and a shift towards
less aggressive respiratory management [4]. These changes have
selectively impacted the survival of extremely preterm infants, and
shifted the occurrence of acute respiratory problems towards lower
gestational age groups [4]. Associated changes in long-term
pulmonary outcomes may have occurred, and there is therefore
a need for a comprehensive, rigorous assessment of the contem-
poraneous evidence base.
We aimed to investigate the association between preterm birth and
childhood wheezing disorders through a systematic review and meta-
analysis of studies with populations born from the 1990s onwards. We
focused on wheezing disorders in general rather than just asthma,
given the difficulty in differentiating between the two, particularly
among young children [11]. Unlike previous work [9], we also
considered the potential impact of confounding factors and explored
the association by degree of prematurity. Based on aggregated
association measures, we have furthermore estimated population-
attributable risks (PARs) to quantify associated disease burden.
Methods
Search Strategy
This review was performed following the methods detailed in a
systematic review protocol registered with PROSPERO
(CRD42013004965; Text S1). Online databases were searched
independently by two authors using the following search terms:
PubMed and Embase: (preterm OR prematur*) AND (asthma OR
wheez*); Google Scholar: asthma, wheeze, wheezing, preterm,
premature, child, children, childhood; World Health Organization
Global Health Library, World Health Organization Library
Information System, SciELO, and Trip [12]: ((preterm OR
premature OR preterms OR prematurity) AND (asthma OR
wheeze OR wheezing)). The searches covered the period from 1
January 1995 to 23 September 2013. No language restrictions
were applied. Additional studies were identified by screening
reference lists of articles of interest and tracing citations of articles
through ISI Web of Knowledge. We asked an international panel
of experts in the field (Text S2) to report any additional published,
unpublished, or in progress studies that might have been missed.
Study Selection
Epidemiological studies were eligible for inclusion if they
reported an association between preterm birth (,37 wk versus
$37 wk gestation [term]) and asthma or wheezing in children
(aged 0.5 to 18 y). Studies reporting on populations that
included children born before 1995 were eligible for inclusion
only when at least 50% of the cohort was born from 1995
onwards and none of the children was born before 1990, so as to
primarily include studies conducted in the period following the
important changes in neonatal practice outlined earlier. When
studies with overlapping data were identified, the most
informative study was selected for inclusion in this report; the
determination of which study was considered most informative
was based on consensus, study size being an important
determinant. Final study selection was based on a consensus
decision between reviewers, with arbitration by a third reviewer
in case of disagreement.
Data Extraction
Data were independently extracted from eligible studies by two
reviewers (J. V. B. and M. J. L.); disagreements were resolved
through discussion, with arbitration by a third reviewer if
necessary (A. S.). The following study characteristics were
extracted: authors, full reference, study design, location, sample
size, inclusion and exclusion criteria, age range and birth year of
study participants, method of ascertainment of exposure and
outcomes, and outcome measure.
Post-term (.42 wk gestation) births were excluded from the
analyses, if possible. If studies reported follow-up at different time
points, the most recent was selected. Similarly to previous work [13],
we used only one outcome measure from each study in the analyses;
for studies with multiple outcome measures, the following hierarchy
was used to select the outcome measure used in the analyses, from
most preferred to least preferred: asthma, persistent wheezing,
recurrent wheezing, severe wheezing, and wheezing. Furthermore,
we used the following hierarchy to select the highest ascertainment
level if the outcome was measured multiple ways: clinician
diagnosis, documented medication use as a wheezing disorder
proxy, routinely collected health-care data, parent- or patient-
reported clinician diagnosis, parent- or patient-reported medication
use, and parent- or patient-reported symptoms. ‘‘Ever’’ wheezing or
asthma was favoured over recent and current wheezing or asthma.
Absolute patient counts were extracted to compose 262 tables
according to preterm birth and wheezing disorder status, and these
were used to calculate univariate odds ratios (ORs); in instances
where relevant crude data were missing, we approached authors to
request these. If needed, count data were calculated from provided
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percentages, and these were then rounded off to the nearest
integer. Adjusted association measures were extracted from the
most adjusted model presented.
Study Quality
Study quality was assessed independently by two investigators
using the Effective Public Health Practice Project quality
assessment tool for quantitative studies [14]. Sex, maternal
smoking during pregnancy, and maternal atopy or asthma, or
a family history of atopy or asthma, were deemed the
most important confounders. Any disagreement was resolved
by consensus and arbitration by a third reviewer, where
necessary.
Statistical Analyses
Univariate association measures were pooled using Mantel-
Haenszel analysis. Random-effects models were applied because
of anticipated heterogeneity given between-country variation in
clinical practice and differences in inclusion and exclusion
criteria, outcome specification, and ascertainment level of
exposure and outcome. Adjusted association measures were
pooled via random-effects generic inverse variance analysis.
Standard errors for study point estimates were calculated from
the respective 95% confidence intervals as described in the
Cochrane Handbook [15].
For studies reporting adjusted association measures according to
multiple gestational age strata, the least preterm stratum was
selected to obtain the most conservative estimate. In a separate
analysis, a linear association between gestational age at birth and
wheezing disorder risk was investigated, pooling individual studies
by random-effects generic inverse variance analysis. For this
purpose, adjusted association measures for multiple gestational age
strata were aggregated within studies using a fixed-effects log-
linear dose–response regression model [16]. The Q-statistic and I2-
test were used to assess heterogeneity among studies. Small-study
effects were assessed using funnel plots and Harbord’s modified
regression test for unadjusted data and Egger’s regression test for
adjusted association measures.
Subgroup Analyses
Subgroup analyses were performed according to age group
(,5 y versus $5 y) and degree of prematurity (,32 wk versus 32–
36 wk). When studies reported the association between preterm
birth and wheezing disorders for both subgroups (i.e., follow-up at
,5 y and at $5 y, and/or reported for ,32 wk and 32–36 wk
gestation), the corresponding association measures were included
in both sides of the comparison.
Sensitivity Analyses
Sensitivity analyses were performed according to risk of bias
(low, moderate, or high), study size (n,10,000 versus n$10,000),
and outcome definition (asthma versus wheezing) and ascertain-
ment (clinician diagnosis and/or medication use versus parent-
reported outcomes).
Meta-Regression Analysis
Meta-regression analysis was performed to assess the inde-
pendent effects of study size, mean age, wheezing type
(wheezing versus asthma), diagnosis ascertainment, and publi-
cation year on the association between preterm birth and
wheezing disorders.
Population-Attributable Risk
PAR was calculated using the following formula:
PAR~
Pe| RRe{1ð Þ
1zPe| RRe{1ð Þ ð1Þ
where Pe is the exposure prevalence and RRe is the relative risk
due to exposure [17]. RRe was calculated as follows:
Figure 1. Flowchart outlining study selection. WHO GHL, World
Health Organization Global Health Library; WHOLIS, World Health
Organization Library Information System.
doi:10.1371/journal.pmed.1001596.g001
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1{PEERð Þz PEER|ORð Þ ð2Þ
where PEER is the patient expected event rate. As estimations of
PAR based on unadjusted association measures can be biased by
confounding of the exposure–outcome relationship, we addition-
ally calculated PAR using aggregated adjusted association
measures via the following formula:
PAR~pd|
RRe{1ð Þ
RRe
ð3Þ
where pd is the proportion of cases exposed [17].
Analyses were performed using Stata 12 (StataCorp).
Role of the Funding Source
The funders had no role in study design, collection, analysis,
interpretation of the data, writing of the report, or decision to
submit the work for publication.
Results
Forty-two eligible studies were identified [18–59]. Study selection
is summarised in Figure 1. Five studies from Sweden
[18,20,36,47,55] and two from northern California, US, had
significant population overlap [28,56]. Furthermore, several eligible
studies described the same cohort: the Epicure cohort, UK and
Ireland (n= 4) [29,34,41,49]; the Boston Birth Cohort, Boston, US
(n= 3) [39,40,44]; a birth cohort from southern New England, US
(n= 2) [27,37]; and cross-sectional surveys from Liverpool, UK
(n= 2) [38,53]. The most relevant study was selected from each set
of overlapping studies. Characteristics of the 12 studies that were
excluded, as well as reasons for exclusion, are given in Table S1.
Meta-analysis was performed on the remaining 30 unique studies
(Tables 1 and 2), which reported on a total of 1,543,639 individuals
[19,21–27,29–33,35,36,42–46,48,50–54,56–59].
Study Quality
Four studies were deemed to have low risk of bias, 12 had
moderate risk of bias, and 14 had high risk of bias (Table S2).
Studies with high risk of bias were generally smaller (median size
756; range 90–7,925) than those with moderate risk (median size
10,246; range 560–397,852) and low risk (median size 6,992;
range 1,448–708,907).
Meta-Analysis of Unadjusted Data
Crude data were provided by authors of five studies
[26,33,46,53,54], and were calculated for seven additional studies
[19,30–32,42,44,59]. Crude data could not be retrieved for four
studies, and these were included in the adjusted meta-analysis only
[21,24,25,45]. Pooling of the 26 studies (1,500,916 individuals) for
which unadjusted data were available showed a significant
association between preterm birth and wheezing disorders (OR
1.71, 95% CI 1.57–1.87, p,0.001; Figure 2). Out of 93,616
children born preterm, 12,858 (13.7%) were diagnosed with a
wheezing disorder, compared to 116,732 out of 1,407,300 children
born at term (8.3%).
Meta-Analysis of Adjusted Data
Seventeen studies provided adjusted association measures that
could be pooled in a meta-analysis (874,710 individuals). Although
the variables for which individual studies adjusted varied (Table S3),
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the majority included the important confounders: sex, maternal
smoking, and parental atopy or asthma. The final summary OR for
the association between preterm birth and wheezing disorders was
slightly attenuated as compared to the unadjusted analysis (OR
1.46, 95% CI 1.29–1.65, p,0.001; Figure 3).
In order to investigate a possible ‘‘dose–response’’ relationship
between gestational age at birth and wheezing disorder risk, we
aggregated corresponding adjusted association measures from 17
studies (1,105,828 individuals; Figure 4). The pooled estimate of the
linear association between gestational age and wheezing disorder
Table 3. Meta-regression analysis according to study characteristics.
Factor Unadjusted Association Measure Adjusted Association Measure
Beta (95% CI) p-Value Beta (95% CI) p-Value
Study size (per 1,000 individuals) 20.000 (20.001 to 0.001) 0.70 0.000 (20.001 to 0.001) 0.93
Median population age (years) 0.033 (20.062 to 0.069) 0.92 0.051 (20.039 to 0.141) 0.24
Asthma (reference =wheezing) 0.102 (20.250 to 0.453) 0.55 0.035 (20.348 to 0.417) 0.85
Doctor diagnosis (reference = parental report) 0.009 (20.333 to 0.352) 0.96 20.010 (20.377 to 0.357) 0.95
Year of publication 0.008 (20.057 to 0.072) 0.80 20.017 (20.093 to 0.058) 0.62
Overall 0.99 0.78
Residual I2 70% 53%
doi:10.1371/journal.pmed.1001596.t003
Figure 2. Meta-analysis of unadjusted association between preterm birth and childhood wheezing disorders. Heterogeneity: I2 = 82%
(95% CI 75%–87%). PTB, preterm birth; WD, wheezing disorders.
doi:10.1371/journal.pmed.1001596.g002
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risk thus obtained (OR 0.94, 95% CI 0.92–0.96, p,0.001) indicated
a 6% (95% CI 4%–8%) decrease in wheezing disorder risk for every
week increase in gestation length up to 40 wk.
Subgroup Analyses
The strength of the association between preterm birth and
wheezing disorders was similar between children aged ,5 y and
older children in both unadjusted and adjusted analyses (Figures
S1, S2, S3). The risk was considerably higher among children born
very preterm (unadjusted: OR 3.00, 95% CI 2.61–3.44, p,0.001;
adjusted: OR 2.81, 95% CI 2.52–3.12, p,0.001; Figure 5) when
compared to moderately preterm children (unadjusted: OR 1.49,
95% CI 1.34–1.66, p,0.001; adjusted: OR 1.37, 95% CI 1.17–
1.62, p,0.001; Figure 6).
Sensitivity Analyses
In adjusted analyses, the association between preterm birth and
wheezing disorders was most pronounced in the higher quality
studies, whereas studies with a high risk of bias had the highest point
estimate in the unadjusted analysis (Figures S4, S5, S6). Aggregate
ORs did not differ much between subgroups according to study size
(Figures S7, S8, S9), diagnosis ascertainment (Figures S10, S11,
S12), or wheezing type (Figures S13, S14, S15).
Meta-Regression Analysis
To further investigate the independent effects of study size,
population age, diagnosis ascertainment, wheezing type, and
publication year, meta-regression analysis was performed. None of
these factors had an independent effect on the strength of
association between preterm birth and wheezing disorders
(Table 3). The models’ residual I2 values suggested that additional
unmeasured factors contributed to between-study heterogeneity.
Small-Study Effects
Funnel plot asymmetry was minimal for both unadjusted and
adjusted association measures (Figure 7). Accordingly, Harbord’s
test (p= 0.55; unadjusted association measures) and Egger’s test
(p= 0.43; adjusted association measures) revealed no important
small-study effects potentially indicative of publication bias.
Population-Attributable Risk
Based on unadjusted association measures, the PAR for
childhood wheezing disorders associated with preterm birth was
estimated at 4.0% overall, comprising 1.6% (95% CI 1.3%–1.9%)
for very preterm birth and 2.4% (95% CI 1.7%–3.1%) for
moderately preterm birth. PAR based on adjusted association
measures was 3.1%: 1.2% (95% CI 1.1%–1.3%) for very preterm
Figure 3. Meta-analysis of adjusted association between preterm birth and childhood wheezing disorders. Subgroups taken from
individual studies noted in parentheses. Heterogeneity: I2 = 80% (95% CI 68%–86%). Individual study adjustment for the primary confounders is
depicted. Additional confounders adjusted for are outlined in Table S3. FH, family history; LRI, lower respiratory infection; PTB, preterm birth; WD,
wheezing disorders.
doi:10.1371/journal.pmed.1001596.g003
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birth and an additional 1.9% (95% CI 1.0%–2.7%) for moderately
preterm birth.
Discussion
In this meta-analysis of observational studies, using data from
over 1.5 million children from across six continents, preterm birth
was found to be associated with a 1.71 (95% CI 1.57–1.87) times
increased risk of childhood wheezing disorders. The association
was slightly attenuated by adjustment for potential confounding
within individual studies (OR 1.46, 95% CI 1.29–1.65). Additional
analyses strongly support a dose–response relationship between
length of gestation and wheezing disorders (OR 0.94, 95% CI
0.92–0.96, per week increase), with children born very preterm
having three times the risk of that of children born at term (OR
3.00, 95% CI 2.61–3.44). Consistency across sensitivity analyses
further supports the robustness of the findings. Moderate preterm
birth accounted for the majority of the explained variation in
childhood wheezing disorders by preterm birth. Together, these
findings are in line with the increasing recognition of the impact
that early life influences have on subsequent health and disease,
including pulmonary outcomes [1,8]. Furthermore, they highlight
the pressing need for prioritisation of research into prevention of
preterm birth and the aetiology of its adverse consequences for
subsequent respiratory health.
As with any systematic review we cannot exclude the possibility
that potentially relevant studies were missed by our search
strategy, although it included the primary online databases for
medical research and the most rational search terms relevant to
the research question. Identification of additional studies was
performed through screening of reference lists and citations, and
contacting an international panel of experts. Absence of important
small-study effects suggests that bias resulting from selective study
inclusion is likely to be minor.
I2 values suggested that considerable heterogeneity was present
among the studies included in the meta-analysis, although these
values may be inflated by the inclusion of some very large studies
[60]. Heterogeneity was handled by applying random-effects
models [15]. Low I2 values in subgroup analyses according to age
group suggest that between-study population age differences may
contribute. Variation furthermore exists among doctors and
parents, and between doctors and parents regarding the definition
and perception of wheeze, as well as asthma. We therefore
performed sensitivity analyses separating wheezing from asthma,
and physician diagnoses from parental reports. The results suggest
that, although perceptions may differ, this did not affect the
Figure 4. Meta-analysis of adjusted dose–response association between gestational age (per week increase) and childhood
wheezing disorders. Heterogeneity: I2 = 90% (95% CI 85%–92%). Individual study adjustment for the primary confounders is depicted. Additional
confounders adjusted for are outlined in Table S3. FH, family history; WD, wheezing disorders.
doi:10.1371/journal.pmed.1001596.g004
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Figure 5. Meta-analysis of association between very preterm birth and childhood wheezing disorders. (A) unadjusted effect estimates;
(B) adjusted effect estimates. Subgroups taken from individual studies noted in parentheses. Heterogeneity: I2 (unadjusted) = 62% (95% CI 9%–79%);
I2 (adjusted) = 0% (95% CI 0%–68%). Confounders adjusted for in individual studies are outlined in Figure 3 and Table S3. LRI, lower respiratory
infection; PTB, preterm birth; WD, wheezing disorders.
doi:10.1371/journal.pmed.1001596.g005
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Figure 6. Meta-analysis of association between moderately preterm birth and childhood wheezing disorders. (A) unadjusted effect
estimates; (B) adjusted effect estimates. Subgroups taken from individual studies noted in parentheses. Heterogeneity: I2 (unadjusted) = 92% (95% CI
87%–94%); I2 (adjusted) = 89% (95% CI 82%–93%). Confounders adjusted for in individual studies are outlined in Figure 3 and Table S3. LRI, lower
respiratory infection; PTB, preterm birth; WD, wheezing disorders.
doi:10.1371/journal.pmed.1001596.g006
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estimation of the association between preterm birth and childhood
wheezing disorders. Indeed, residual heterogeneity remained after
adjustment for these and other factors via meta-regression analysis.
Although study quality may be another responsible factor, the
observation that aggregated association measures were most
pronounced in studies with low risk of bias supports the validity
of the conclusions.
Several factors potentially confound the association between
preterm birth and wheezing disorders [9]. We therefore performed
separate analyses aggregating adjusted association measures. This
attenuated the association between preterm birth and wheezing
disorders to some degree, as expected. The vast majority of studies
adjusted for important potential confounders, although their
number and nature varied between studies. A varying degree of
residual confounding thus remains, which should be taken into
account when interpreting the findings. From studies reporting
association measures according to multiple gestational age strata
we included the least preterm stratum. The aggregated point
estimate is therefore likely to underestimate the actual association.
Different methods for gestational age estimation exist. Although
most studies failed to report their approach, first trimester
ultrasound is increasingly used in higher income countries.
Alternative estimation is usually based on the last menstrual
period, which is known to overestimate the numbers of preterm
and post-term births [61]. Again, this is expected to result in
underestimation of the association between preterm birth and
wheezing disorders [62].
In a previous meta-analysis, preterm birth was associated with a
1.37 (95% CI 1.30–1.43) times increased risk of asthma [9]. To
better reflect current neonatal practice, we included only cohorts
born from the 1990s onwards, resulting in a much larger sample
size and negligible overlap with the report by Jaakkola and
colleagues [9]. The substantially greater numbers of events in
our review enabled us—for the first time—to investigate aggre-
gated adjusted association estimates to account for potential
confounding, explore the association with degree of prematurity
(i.e., a dose-dependent relationship), and estimate the associated
disease burden (i.e., PAR). These additional steps are crucial to
interpreting these data, as the evidence is of necessity derived from
observational studies, which are inherently at risk of bias. We can
only speculate as to the underlying reasons for the association
being more pronounced in our report, even after adjustment for
confounding. The former review mainly included children born in
the 1960s–1980s [9]. These older cohorts are likely to be less
preterm on average, which may explain their somewhat lower risk
of developing asthma. Analysis by study characteristics in both
meta-analyses suggests that the study characteristics are unlikely to
explain the difference. The apparent increase over time in
wheezing disorder risk associated with preterm birth indicates
that changes in neonatal practice have generally failed to improve
obstructive pulmonary outcomes in children born preterm.
The current findings do not support prior suggestions that the
association between preterm birth and wheezing disorders
becomes less prominent with increasing age [9]. Instead, the
strength of the association was similar across age groups,
suggesting that the pulmonary consequences of preterm birth
tend to persist throughout the life course. This observation is
supported by evidence from longitudinal studies showing temporal
tracking of small airway disease among individuals born preterm
[54,56,63], and by recent confirmation of a link between preterm
birth and chronic obstructive pulmonary disease [8]. The contribu-
tion of atopy to this association is unclear and requires further study.
The processes underlying preterm birth are poorly understood
[64]. The incidence as well as the underlying causes of preterm
birth are known to vary both geographically and temporally, at
least partially driven by meteorological, socioeconomic, ethnic,
and (epi)genetic variation [2,64–66]. Environmental exposures,
such as pollution and tobacco smoke, and individual behavioural
differences (i.e., hygiene, smoking during pregnancy) furthermore
contribute [64,65]. Many such factors have also been linked to the
development of wheezing disorders [40,44,67]. Through interfer-
ence with the foetus’s natural environment during critical windows
of development, the processes underlying preterm birth challenge
the developmental plasticity of the lungs and airways [1,4,43].
Common antecedents of preterm birth such as inflammation,
maternal smoking, metabolic derangement, hypoxia, and growth
restriction have well-recognised adverse effects on lung maturation
and structure, T cell polarisation and development, and airway
reactivity [4,31,67–69]. Such alterations can differentially affect
susceptibility of the lungs to injurious exposures that commonly
follow preterm birth, including sepsis, respiratory infections,
mechanical ventilation, and hyperoxia [11,70–72]. For any of
Figure 7. Funnel plots for studies reporting unadjusted and adjusted association measures. (A) unadjusted association measures; (B)
adjusted association measures.
doi:10.1371/journal.pmed.1001596.g007
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these factors, the likelihood of being exposed increases with
decreasing gestational age at birth. Immediate adverse effects are
seen in very preterm infants developing BPD, which is an
independent risk factor for reactive airway disease [5,29,35,49,67].
Preterm birth furthermore augments the association of several of
these risk factors, such as antenatal inflammation and smoke
exposure, with childhood wheezing [31,44]. Such mechanisms
may all contribute to the observed dose–response relationship
between gestational age and adverse respiratory outcomes, includ-
ing wheezing disorders [4,31]. Genetic influences and gene–
environment interactions are furthermore likely to play a role,
and the link between preterm birth and asthma has been suggested
to at least partially reflect a common genetic background [9,73].
The magnitude of the problem having been established, there is
now a pressing need to address several knowledge gaps. Epidemi-
ological studies should concentrate on temporal tracking of
respiratory status into adulthood following preterm birth, with
particular focus on different wheezing phenotypes, and estimating
the relative impact of distinct early life factors on these patterns.
Recent accomplishments in combining European birth cohorts can
help provide the required numbers [74]. There is, furthermore, a
need for additional studies from low- and middle-income countries.
More high-quality research is required to identify the underlying
mechanisms and accordingly develop appropriate preventive and
therapeutic measures. Innovative approaches may combine these
aspects, as recently highlighted by a randomised controlled trial of
repeated administration of a monoclonal respiratory syncytial virus
antibody in moderately preterm infants [75]. The intervention
induced an important decrease in wheezing in the first year,
establishing the causal link between respiratory syncytial virus and
wheezing, as well as offering a possible solution [75]. Immune
modulation is beginning to fulfil its promise in neonatal medicine,
and preterm babies may well prove particularly favourable targets
for the immunomodulatory therapies that are likely to shape the
future of asthma management [69,76,77]. The potential for
stratified medicine to benefit children born preterm needs to be
more generally explored through appropriately designed trials and
pre-specified subgroup analyses in future trials.
This work provides compelling evidence that preterm birth is an
important early life risk factor for wheezing disorders in childhood.
Given the increasing incidence of both entities and their
potentially lifelong consequences, there is an urgent need to
identify the underlying mechanisms and explore the potential for
preventive and therapeutic approaches.
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Figure S1 Meta-analysis of unadjusted association
between preterm birth and childhood wheezing disor-
ders according to age group. Since estimates from Boyle [22]
and Vrijlandt [48] are included on both sides of the comparison,
overall association measures are not displayed. Subgroups taken
from individual studies noted in parentheses. Heterogeneity: I2
(,5 y) = 56% (95% CI 0%–76%); I2 ($5 y) = 48% (95% CI 0%–
72%). PTB, preterm birth; WD, wheezing disorders.
(TIF)
Figure S2 Meta-analysis of adjusted association be-
tween preterm birth and childhood wheezing disorders
according to age group. Since estimates from Boyle [22] are
included on both sides of the comparison, overall association
measures are not displayed. Subgroups taken from individual
studies noted in parentheses. Confounders adjusted for in individual
studies are outlined in Figure 3 and Table S3. Heterogeneity: I2
(,5 y) = 31% (95% CI 0%–77%); I2 ($5 y) = 41% (95% CI 0%–
69%). PTB, preterm birth; WD, wheezing disorders.
(TIF)
Figure S3 Meta-analysis of adjusted dose–response
association between gestational age (per week increase)
and childhood wheezing disorders according to age
group. Since estimates from Boyle [22] are included on both
sides of the comparison, overall association measures are not
displayed. Subgroups taken from individual studies noted in
parentheses. Confounders adjusted for in individual studies are
outlined in Figure 4 and Table S3. Heterogeneity: I2 (,5 y) = 0%
(95% CI 0%–68%); I2 ($5 y) = 37% (95% CI 0%–69%). WD,
wheezing disorders.
(TIF)
Figure S4 Meta-analysis of unadjusted association
between preterm birth and childhood wheezing disor-
ders according to risk of bias. Heterogeneity: I2 (high risk of
bias) = 60% (95% CI 10%–77%); I2 (moderate risk of bias) = 63%
(95% CI 0%–80%); I2 (low risk of bias) = 0% (95% CI 0%–68%).
PTB, preterm birth; WD, wheezing disorders.
(TIF)
Figure S5 Meta-analysis of adjusted association be-
tween preterm birth and childhood wheezing disorders
according to risk of bias. Subgroups taken from individual
studies noted in parentheses. Confounders adjusted for in
individual studies are outlined in Figure 3 and Table S3.
Heterogeneity: I2 (high risk of bias) = 56% (95% CI 0%–82%);
I2 (moderate risk of bias) = 46% (95% CI 0%–73%); I2 (low risk of
bias) = 0% (95% CI 0%–68%). PTB, preterm birth; WD,
wheezing disorders.
(TIF)
Figure S6 Meta-analysis of adjusted dose–response
association between gestational age (per week increase)
and childhood wheezing disorders according to risk of
bias. Confounders adjusted for in individual studies are outlined
in Figure 4 and Table S3. Heterogeneity: I2 (high risk of
bias) = 39% (95% CI 0%–76%); I2 (moderate risk of bias) = 63%
(95% CI 0%–81%); I2 (low risk of bias) = 8% (95% CI 2%–90%).
WD, wheezing disorders.
(TIF)
Figure S7 Meta-analysis of unadjusted association
between preterm birth and childhood wheezing disor-
ders according to study size. Heterogeneity: I2
(n,10,000) = 47% (95% CI 0%–67%); I2 (n$10,000) = 95%
(95% CI 93%–97%). PTB, preterm birth; WD, wheezing
disorders.
(TIF)
Figure S8 Meta-analysis of adjusted association be-
tween preterm birth and childhood wheezing disorders
according to study size. Subgroups taken from individual
studies noted in parentheses. Confounders adjusted for in
individual studies are outlined in Figure 3 and Table S3.
Heterogeneity: I2 (n,10,000) = 42% (95% CI 0%–68%); I2
(n$10,000) = 94% (95% CI 89%–96%). PTB, preterm birth;
WD, wheezing disorders.
(TIF)
Figure S9 Meta-analysis of adjusted dose–response
association between gestational age (per week increase)
and childhood wheezing disorders according to study
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size. Confounders adjusted for in individual studies are outlined
in Figure 4 and Table S3. Heterogeneity: I2 (n,10,000) = 39%
(95% CI 0%–68%); I2 (n$10,000) = 97% (95% CI 95%–98%).
WD, wheezing disorders.
(TIF)
Figure S10 Meta-analysis of unadjusted association
between preterm birth and childhood wheezing disor-
ders according to diagnosis ascertainment. Heterogeneity:
I2 (parent reported) = 19% (95% CI 0%–55%); I2 (doctor
diagnosed) = 93% (95% CI 89%–95%). PTB, preterm birth;
WD, wheezing disorders.
(TIF)
Figure S11 Meta-analysis of adjusted association be-
tween preterm birth and childhood wheezing disorders
according to diagnosis ascertainment. Subgroups taken
from individual studies noted in parentheses. Confounders
adjusted for in individual studies are outlined in Figure 3 and
Table S3. Heterogeneity: I2 (parent reported) = 43% (95% CI 0%–
71%); I2 (doctor diagnosed) = 90% (95% CI 82%–93%). PTB,
preterm birth; WD, wheezing disorders.
(TIF)
Figure S12 Meta-analysis of adjusted dose–response
association between gestational age (per week increase)
and childhood wheezing disorders according to diagno-
sis ascertainment. Confounders adjusted for in individual
studies are outlined in Figure 4 and Table S3. Heterogeneity: I2
(parent reported) = 54% (95% CI 0%–76%); I2 (doctor diag-
nosed) = 95% (95% CI 92%–96%). WD, wheezing disorders.
(TIF)
Figure S13 Meta-analysis of unadjusted association
between preterm birth and childhood wheezing disor-
ders according to wheezing type. Heterogeneity: I2 (wheez-
ing) = 52% (95% CI 0%–76%); I2 (asthma) = 86% (95% CI 79%–
90%). PTB, preterm birth; WD, wheezing disorders.
(TIF)
Figure S14 Meta-analysis of adjusted association be-
tween preterm birth and childhood wheezing disorders
according to wheezing type. Subgroups taken from individual
studies noted in parentheses. Confounders adjusted for in
individual studies are outlined in Figure 3 and Table S3.
Heterogeneity: I2 (wheezing) = 41% (95% CI 0%–74%); I2
(asthma) = 86% (95% CI 76%–90%). PTB, preterm birth; WD,
wheezing disorders.
(TIF)
Figure S15 Meta-analysis of adjusted dose–response
association between gestational age (per week increase)
and childhood wheezing disorders according to wheez-
ing type. Confounders adjusted for in individual studies are
outlined in Figure 4 and Table S3. Heterogeneity: I2 (wheez-
ing) = 52% (95% CI 0%–78%); I2 (asthma) = 92% (95% CI 87%–
94%). WD, wheezing disorders.
(TIF)
Table S1 Characteristics of studies excluded because of
population overlap. *Selected inhaled or systemic adrenergics,
anticholinergics, xantines, antiallergics, leukotriene receptor an-
tagonists, and/or steroids; ** as compared to preterm babies
without BPD. GA, gestational age; KFHP, Kaiser Foundation
Health Plan; KPMCP, Kaiser Permanente Medical Care
Program; N/R, not reported; LMP, last menstrual period; SD,
standard deviation.
(DOCX)
Table S2 Assessment of study quality. Scoring according
to the Effective Public Health Practice Project quality assessment
tool for quantitative studies. For study design ‘‘7’’ indicates cross-
sectional design in all cases. N/A, not applicable.
(DOCX)
Table S3 Covariates in multivariate models of individ-
ual studies associating preterm birth with wheezing
disorders. amonth of conception, maternal urinary tract
infection, pre-labour rupture of membranes, prostaglandin
induction, neonatal jaundice, neonatal sepsis; bthreatened miscar-
riage, infections, asphyxia, birth trauma, premature rupture of
membranes, umbilical cord knots, placenta problems; cCC10
G+38A polymorphisms, cord blood IgE.
(DOCX)
Text S1 PROSPERO-registered review protocol.
(PDF)
Text S2 Expert panel.
(DOCX)
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Editors’ Summary
Background. Most pregnancies last around 40 weeks, but
worldwide, more than 11% of babies are born before 37
weeks of gestation (the period during which a baby develops
in its mother’s womb). Preterm birth is a major cause of
infant death—more than 1 million babies die annually from
preterm birth complications—and the number of preterm
births is increasing globally. Multiple pregnancies, infections,
and chronic (long-term) maternal conditions such as diabe-
tes can all cause premature birth, but the cause of many
preterm births is unknown. The most obvious immediate
complication that is associated with preterm birth is
respiratory distress syndrome. This breathing problem, which
is more common in early preterm babies than in near-term
babies, occurs because the lungs of premature babies are
structurally immature and lack pulmonary surfactant, a
unique mixture of lipids and proteins that coats the inner
lining of the lungs and helps to prevent the collapse of the
small air sacs in the lungs that absorb oxygen from the air.
Consequently, preterm babies often need help with their
breathing and oxygen supplementation.
Why Was This Study Done? Improvements in the
management of prematurity mean that more preterm babies
survive today than in the past. However, accumulating
evidence suggests that early life events are involved in the
subsequent development of non-communicable diseases
(non-infectious chronic diseases). Given the increasing
burden of preterm birth, a better understanding of the
long-term effects of preterm birth is essential. Here, the
researchers investigate the risks of asthma and wheezing
disorders in children who are born preterm by undertaking a
systematic review (a study that uses predefined criteria to
identify all the research on a given topic) and a meta-analysis
(a statistical method for combining the results of several
studies). Asthma is a chronic condition that is caused by
inflammation of the airways. In people with asthma, the
airways can react very strongly to allergens such as animal
fur and to irritants such as cigarette smoke. Exercise, cold air,
and infections can also trigger asthma attacks, which can
sometimes be fatal. The symptoms of asthma include
wheezing (a high-pitched whistling sound during breathing),
coughing, chest tightness, and shortness of breath. Asthma
cannot be cured, but drugs can relieve its symptoms and
prevent acute asthma attacks.
What Did the Researchers Do and Find? The researchers
identified 30 studies undertaken between 1995 and the
present (a time span chosen to allow for recent changes in
the management of prematurity) that investigated the
association between preterm birth and asthma/wheezing
disorders in more than 1.5 million children. Across the
studies, 13.7% of preterm babies developed asthma/wheez-
ing disorders during childhood, compared to only 8.3% of
babies born at term. Thus, the risk of preterm babies
developing asthma or a wheezing disorder during childhood
was 1.71 times higher than the risk of term babies
developing these conditions (an unadjusted odds ratio
[OR] of 1.71). In analyses that allowed for confounding
factors—other factors that affect the risk of developing
asthma/wheezing disorders such as maternal smoking—the
risk of preterm babies developing asthma or a wheezing
disorder during childhood was 1.46 times higher than that of
babies born at term (an adjusted OR of 1.46). Notably,
compared to children born at term, children born very early
(before 32 weeks of gestation) had about three times the risk
of developing asthma/wheezing disorders in unadjusted and
adjusted analyses. Finally, the population-attributable risk of
preterm birth for childhood wheezing disorders was more
than 3.1%. That is, if no preterm births had occurred, there
would have been more than a 3.1% reduction in childhood
wheezing disorders.
What Do These Findings Mean? These findings strongly
suggest that preterm birth increases the risk of asthma and
wheezing disorders during childhood and that the risk of
asthma/wheezing disorders increases as the degree of
prematurity increases. The accuracy of these findings may
be affected, however, by residual confounding. That is,
preterm children may share other, unknown characteristics
that increase their risk of developing asthma/wheezing
disorders. Moreover, the generalizability of these findings is
limited by the lack of data from low- and middle-income
countries. However, given the projected global increases in
children surviving preterm births, these findings highlight
the need to undertake research into the mechanisms
underlying the association between preterm birth and
asthma/wheezing disorders and the need to develop
appropriate preventative and therapeutic measures.
Additional Information. Please access these websites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1001596.
N The March of Dimes, a nonprofit organization for
pregnancy and baby health, provides information on
preterm birth (in English and Spanish)
N Nemours, another nonprofit organization for child health,
also provides information (in English and Spanish) on
premature babies and on asthma (including personal
stories)
N The UK National Health Service Choices website provides
information about premature labor and birth and a real
story about having a preterm baby; it provides information
about asthma in children (including real stories)
N The MedlinePlus Encyclopedia has pages on preterm birth,
asthma, asthma in children, and wheezing (in English and
Spanish); MedlinePlus provides links to further information
on premature birth, asthma, and asthma in children (in
English and Spanish)
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